Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Brandeis

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Annals of the New York Academy of Sciences|September 24, 1993
Selective signaling via unique M1 muscarinic agonistsA Fisher, E Heldman, D Gurwitz, et al.
Drug Design and Discovery|January 1, 1993
Progress in medicinal chemistry of novel selective muscarinic agonistsA Fisher, Y Karton, E Heldman, et al.
Alzheimer Disease and Associated Disorders|January 1, 1994
Transdermal physostigmine in the treatment of Alzheimer's diseaseA Levy, R Brandeis, T A Treves, et al.
Journal of Physiology, Paris|October 28, 1998
Novel m1 muscarinic agonists in treatment and delaying the progression of Alzheimer's disease: an unifying hypothesisA Fisher, R Brandeis, R Haring, et al.
Annals of the New York Academy of Sciences|January 17, 1996
M1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical updateA Fisher, E Heldman, D Gurwitz, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Annals of the New York Academy of Sciences|September 24, 1993
Selective signaling via unique M1 muscarinic agonistsA Fisher, E Heldman, D Gurwitz, et al.
Drug Design and Discovery|January 1, 1993
Progress in medicinal chemistry of novel selective muscarinic agonistsA Fisher, Y Karton, E Heldman, et al.
Alzheimer Disease and Associated Disorders|January 1, 1994
Transdermal physostigmine in the treatment of Alzheimer's diseaseA Levy, R Brandeis, T A Treves, et al.
Journal of Physiology, Paris|October 28, 1998
Novel m1 muscarinic agonists in treatment and delaying the progression of Alzheimer's disease: an unifying hypothesisA Fisher, R Brandeis, R Haring, et al.
Annals of the New York Academy of Sciences|January 17, 1996
M1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical updateA Fisher, E Heldman, D Gurwitz, et al.
Pageof 3